1-5 of 5
Stephanie J Kraftson
Close
Sort by
Journal Articles

Effects Of Inhibition Of XPO1/CRM1-Dependent Nuclear Export By Selinexor (KPT-330), Alone and In Combination With Carfilzomib (CFZ), On Apoptosis and Autophagy In Multiple Myeloma (MM)

Shaun Rosebeck, PhD, Malathi Kandarpa, PhD, Mattina M. Alonge, Jagoda Jasielec, MD, Dominik Dytfeld, MD, PhD, Sean P Maxwell, Stephanie J Kraftson, Dilara McCauley, PhD, Sharon Shacham, PhD, MBA, Michael Kauffman, MD, PhD, Andrzej J. Jakubowiak, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 279.
https://doi.org/10.1182/blood.V122.21.279.279
Published: 2013
Journal Articles

CRM1 Is Highly Expressed in Myeloma Plasma Cells and Its Inhibition by KPT-SINE Induces Cytotoxicity by Increasing p53 in the Nucleus of Multiple Myeloma (MM) Cells

Malathi Kandarpa, PhD, Stephanie J Kraftson, Sean P Maxwell, Dilara McCauley, PhD, Sharon Shacham, PhD, MBA, Michael Kauffman, Andrzej J Jakubowiak, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1852.
https://doi.org/10.1182/blood.V118.21.1852.1852
Published: 2011
Journal Articles

Proteomic Signature Predicting Achievement of Very Good Partial Response In Patients with Multiple Myeloma Based On Complementary Label-Free and iTRAQ Quantitative Proteome Analysis

Dominik Dytfeld, MD, PhD, Malathi Kandarpa, PhD, John R Strahler, PhD, Dattatreya Mellacheruvu, Suchitra Subramani, Stephanie J Kraftson, Lambert Ngoka, PhD, Alexey Nesvizhskii, PhD, Arun Sreekumar, PhD, Andrzej J Jakubowiak, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1902.
https://doi.org/10.1182/blood.V116.21.1902.1902
Published: 2010
Journal Articles

Proteomic Profiling of Multiple Myeloma (MM) Cells Using iTRAQ and Label-Free Quantitative Proteomics for the Prediction of Complete or near Complete Response (CR/nCR) In Frontline Treatment with Lenalidomide, Bortezomib, and Dexamethasone

Dominik Dytfeld, MD, PhD, Malathi Kandarpa, PhD, John R Strahler, PhD, Dattatreya Mellacheruvu, Suchitra Subramani, Stephanie J Kraftson, Lambert Ngoka, PhD, Alexey Nesvizhskii, PhD, Arun Sreekumar, PhD, Paul G Richardson, MD, Andrzej J Jakubowiak, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 618.
https://doi.org/10.1182/blood.V116.21.618.618
Published: 2010
Journal Articles

Proteomic Profiling of Multiple Myeloma Plasma Cells and Normal Plasma Cells Reveals Differential Expression of Clu1 and Basp1 Proteins

Dominik Dytfeld, MD, PhD, Malathi Kandarpa, PhD, Stephanie J Kraftson, John R Strahler, PhD, Dattatreya Mellacheruvu, Suchitra Subramani, Alexey Nesvizhskii, PhD, Andrzej J Jakubowiak, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4034.
https://doi.org/10.1182/blood.V116.21.4034.4034
Published: 2010